When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Tofacitinib - Wikipedia

   en.wikipedia.org/wiki/Tofacitinib

   The FDA approved only the five-mg, twice-daily dose on the grounds that a higher dose was not considered to have an adequate risk-to-benefit ratio. [34] In September 2020, the FDA approved tofacitinib for the treatment of children and adolescents two years of age and older with active polyarticular course juvenile idiopathic arthritis. [35]

3. FDA approves new treatment for vitiligo patients - AOL

   www.aol.com/news/fda-approves-treatment-vitiligo...

   The FDA approved opzelura cream this year, to treat vitiligo in adult and pediatric patients 12 years of age and older.

4. Pfizer Gets FDA Panel Backing for New Indication for Xeljanz

   www.aol.com/news/pfizer-gets-fda-panel-backing...

   For premium support please call: 800-290-4726 more ways to reach us

5. Pfizer Announces FDA Acceptance for Review of Application to ...

   www.aol.com/2013/06/21/pfizer-announces-fda...

   Pfizer Announces FDA Acceptance for Review of Application to Expand Labeling for XELJANZ ® (tofacitinib citrate) for Adults with Moderately to Severely Active Rheumatoid Arthritis to Include ...

6. PUVA therapy - Wikipedia

   en.wikipedia.org/wiki/PUVA_therapy

   PUVA (psoralen and UVA) is an ultraviolet light therapy treatment for skin diseases: vitiligo, eczema, psoriasis, graft-versus-host disease, mycosis fungoides, large plaque parapsoriasis, and cutaneous T-cell lymphoma, using the sensitizing effects of the drug psoralen.

7. Vitiligo - Wikipedia

   en.wikipedia.org/wiki/Vitiligo

   Vitiligo (/ ˌ v ɪ t ɪ ˈ l aɪ ɡ oʊ /, vi-ti-leye-goh) is a chronic autoimmune disorder that causes patches of skin to lose pigment or color. [1] The cause of vitiligo is unknown, but it may be related to immune system changes, genetic factors, stress, or sun exposure. [5] [6] Treatment options include topical medications, light therapy ...